Simulations Plus (NASDAQ:SLP) Shares Pass Above 200-Day Moving Average of $40.99

Shares of Simulations Plus, Inc. (NASDAQ:SLPGet Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $40.99 and traded as high as $45.96. Simulations Plus shares last traded at $45.65, with a volume of 141,941 shares.

Wall Street Analysts Forecast Growth

Separately, Craig Hallum increased their target price on Simulations Plus from $50.00 to $51.00 and gave the stock a “buy” rating in a report on Thursday, January 4th.

Read Our Latest Research Report on SLP

Simulations Plus Stock Down 2.1 %

The business’s 50 day simple moving average is $43.59 and its two-hundred day simple moving average is $40.99. The stock has a market cap of $912.54 million, a P/E ratio of 86.13 and a beta of 0.72.

Simulations Plus (NASDAQ:SLPGet Free Report) last issued its quarterly earnings results on Wednesday, April 3rd. The technology company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.02. The company had revenue of $18.31 million for the quarter, compared to analyst estimates of $17.31 million. Simulations Plus had a net margin of 16.22% and a return on equity of 7.95%. Simulations Plus’s revenue was up 16.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.20 earnings per share. As a group, research analysts forecast that Simulations Plus, Inc. will post 0.67 earnings per share for the current fiscal year.

Simulations Plus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, May 6th. Shareholders of record on Monday, April 29th will be given a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date of this dividend is Friday, April 26th. Simulations Plus’s payout ratio is 45.28%.

Insider Activity

In other news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $39.94, for a total transaction of $798,800.00. Following the completion of the transaction, the director now directly owns 3,600,195 shares of the company’s stock, valued at approximately $143,791,788.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $39.94, for a total transaction of $798,800.00. Following the sale, the director now directly owns 3,600,195 shares in the company, valued at approximately $143,791,788.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Walter S. Woltosz sold 18,945 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $38.02, for a total transaction of $720,288.90. Following the sale, the director now owns 3,641,250 shares in the company, valued at $138,440,325. The disclosure for this sale can be found here. Insiders own 20.90% of the company’s stock.

Hedge Funds Weigh In On Simulations Plus

Institutional investors have recently made changes to their positions in the stock. Conestoga Capital Advisors LLC grew its holdings in shares of Simulations Plus by 12.5% during the 4th quarter. Conestoga Capital Advisors LLC now owns 2,259,176 shares of the technology company’s stock valued at $101,098,000 after purchasing an additional 251,299 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Simulations Plus by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 1,118,878 shares of the technology company’s stock valued at $46,657,000 after purchasing an additional 5,009 shares during the last quarter. Ranger Investment Management L.P. grew its holdings in shares of Simulations Plus by 1.4% during the 4th quarter. Ranger Investment Management L.P. now owns 931,132 shares of the technology company’s stock valued at $41,668,000 after purchasing an additional 12,505 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Simulations Plus by 1.1% during the 3rd quarter. Invesco Ltd. now owns 469,958 shares of the technology company’s stock valued at $19,597,000 after purchasing an additional 5,107 shares during the last quarter. Finally, Wasatch Advisors LP grew its holdings in shares of Simulations Plus by 36.5% during the 1st quarter. Wasatch Advisors LP now owns 381,693 shares of the technology company’s stock valued at $15,707,000 after purchasing an additional 102,135 shares during the last quarter. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Company Profile

(Get Free Report)

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

Featured Articles

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.